Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drug combo safety check in healthy volunteers

NCT ID NCT07425899

Recruiting now Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 1 study tests how two oral drugs, ABBV-722 and upadacitinib, affect each other in the body. Thirty-two healthy adults will take multiple doses to measure drug levels and check for side effects. The goal is to understand safety and drug interactions, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ABBV-722 and upadacitinib (oral drugs)

What could go wrong

This is an early-stage study in healthy people, not patients. It only checks drug levels and short-term safety, so it won't show if the drugs work for any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Acpru /Id# 279285

    RECRUITING

    Grayslake, Illinois, 60030, United States